1332856-06-0

Basic information

• Product Name: C₁₆H₁₄O₇
• Synonyms: C₁₆H₁₄O₇
• CAS NO: 1332856-06-0
• Molecular Weight: 318.283
• Mol File: 1332856-06-0.mol

Chemical Properties

• CAS DataBase Reference: C₁₆H₁₄O₇(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₆H₁₄O₇(1332856-06-0)
• EPA Substance Registry System: C₁₆H₁₄O₇(1332856-06-0)

Safety Data

• Hazardous Substances Data: 1332856-06-0(Hazardous Substances Data)

Upstream product

• 31600-43-8 methyl 2-(benzyloxy)acetate 
• 30379-55-6 benzyloxyacetic acid 
• 19810-31-2 Benzyloxyacetyl chloride 

Downstream Products

• 1332856-07-1 C₂₄H₁₉FN₂O₅S 
• 1616599-83-7 N-(3-chloro-2-fluorobenzyl)-2’-ethyl-9’-hydroxy-trans-3-methoxy-1‘,8’-dioxo-1‘,2’,4’,8’-tetrahydrospiro[cyclobutane-1,3’-pyrido[1,2-a]pyrazine]-7’-carboxamide 
• 1616599-75-7 N-(3-chloro-2-fluorobenzyl)-9’-hydroxy-cis-3-(methoxymethyl)-2’-methyl-1’,8’-dioxo-1’,2’,3’,8’-tetrahydrospiro[cyclobutane-1,4’-pyrido[1,2-a]pyrazine]-7’-carboxamide 

Relevant articles and documents

SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

The present invention relates to Spirocyclic Heterocycle Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, X, Y, R1, R2 and R11 are as defined herein. The present invention also relates to compositions comprising at least one Spirocyclic Heterocycle Compound, and methods of using the Spirocyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.

SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

Disclosed are Spirocyclic Heterocycle Compounds of Formula (I) and pharmaceutically acceptable salts thereof, where A, B, X, Y, R1, R2 and R11 are as defined herein. Composition comprising at least one Spirocyclic Heterocycle Compound, and methods of using the Spirocyclic Heterocycle Compounds for treating or preventing HIV infection in a subject are also disclosed.

4-PYRIDINONETRIAZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS

The present invention relates to 4-Pyridinonetriazine Derivatives of Formula (I); and pharmaceutically acceptable salts thereof, wherein A, X, Y, R1, R2, R3 and R5 are as defined herein. The present invention also relates to compositions comprising at least one 4-Pyridinonetriazine Derivative, and methods of using the 4-Pyridinonetriazine Derivatives for treating or preventing HIV infection in a subject.

SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR

Provided is a substituted spiropyrido[1,2-a]pyrazine derivative or a pharmaceutically acceptable salt thereof, which is useful as an anti-HIV agent. The present invention relates to a compound represented by the following formula [I] or [II] or a pharmace

1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyradine Derivatives and Use Thereof as HIV Integrase Inhibitor

[Problem] Provided is a novel 1,3,4,8-tetrahydro-2H-pyrido[1,2-a]pyrazine derivative or a pharmaceutically acceptable salt thereof, or a solvate thereof, which is useful as an anti-HIV agent. [Solving Means] The present invention provides a compound repre